UK's Tougher New Advertising Rules

23 January 1995

The UK Committee of Advertising Practice issued tougher new rules last week on all advertisements and promotions in print and other non-broadcast media, and in a new development, all non-broadcast interactive media. In the first major review since 1988, the british Codes of Advertising and Sales Promotion have been updated "to reflect the industry's concern that advertisements should be truthful and socially responsible," says the Advertising Standards Authority.

The new rules, which take effect from February 1, are broad ranging, and take account of changes in attitudes that have taken place in the last five years, both in society generally and the marketplace, says the ASA. Within the health care sector, the issue of slimmers' diseases, especially among the under-18s, is addressed for the first time, and the use of celebrities or health professionals to advertise or endorse medicines is proscribed.

The new rules also state that:

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight